RVP: retractable.com Company Value to Net Income

Retractable Tech - graphic logo of issuer RVP

Retractable Technologies (RVP) is developing the VanishPoint safety needle system, creating strong clinic loyalty to its safety standards. This daily price action reflects this process, with the P/E ratio currently at -4.70. The business relies on nearly full automation of its syringe production facilities and the strategic allocation of orders among Asian partner plants to ensure an uninterrupted market supply.

Retractable Technologies, Inc. (RVP) Price to Earnings Ratio: for the period 07/04/2022 - 11/10/2026

Analytical breakdowns for Retractable Technologies Inc. (RVP)

- stock quotes and analyst forecast:
Comprehensive company analysis:retractable.com - RVP
Manufactured product of Retractable Technologies, Inc.

This multiple compares the current market share price to the net profit per share, allowing for the determination of whether the asset is overvalued or if the business is undervalued. The stability of government contracts and the localization of Retractable Technologies (RVP) production minimize earnings volatility; therefore, changes in the company's P/E ratio serve as an accurate indicator of market expectations regarding the sustainability of its capitalization.

Competing companies

Price to Earnings Ratio ISRG|Price to Earnings Ratio DHR (Danaher)|BDX (BD) - Company Value to Net Income|P/E Multiple STE (STERIS Corporation)|Business Payback Period West Pharma Corp (WST)|BAX - Price to Earnings Ratio|MASI (masimo.com) - Price to Earnings Multiple|Stevanato Group (STVN) - Price to Earnings Ratio|TFX - Business Payback Period|Price to Earnings Ratio MMSI|NVST (Nobel Biocare) - Market Price to Net Income Ratio|Price to Earnings Ratio ICU Medical, Inc. (ICUI)|XRAY (dentsplysirona.com) - Company Value to Net Income|LeMaitre Vascular - Price to Earnings Ratio|P/E Multiple AtriCure Inc ATRC|STAA - Price to Earnings Ratio|Chromadex Corp (NAGE) - Price to Earnings Ratio|ZIMV: P/E Multiple|Market Cap to Earnings angiodynamics.com (ANGO)|Price to Earnings Ratio Cerus|Price to Earnings Multiple TKNO (Alpha Teknova)|Price to Earnings Ratio MGRM (Monogram Technologies Inc)|Market Price to Net Income Ratio STSS|Price to Earnings Ratio InfuSystem Holdings, Inc. INFU|Business Payback Period utahmed.com (UTMD)|KRMD - Price to Earnings Ratio|Company Value to Net Income NYXH (Nyxoah SA)|MBOT: P/E Multiple|Market Cap to Earnings Pro-Dex Inc. (PDEX)|Price to Earnings Ratio ZTEK|ELUT (elutia.com) - Market Price to Net Income Ratio|Price to Earnings Ratio Milestone Scientific Inc. (MLSS)|NXGL (NEXGEL Inc.) - Company Value to Net Income|P/E Multiple HBIO (Harvard Bioscience)|P/E Multiple Femasys Corporation FEMY|Meihua Medical - P/E Multiple|Predictive Oncology (POAI) - Price to Earnings Ratio|CJMB (callanjmb.com) - Price to Earnings Ratio|ATRI: Market Price to Net Income Ratio|NURO (NeuroMetrix Corp) - P/E Multiple